Oxford Nanopore Technologies (LON:ONT – Free Report) had its price target decreased by Berenberg Bank from GBX 350 ($4.43) to GBX 282 ($3.57) in a research report sent to investors on Wednesday morning, Digital Look reports. Berenberg Bank currently has a buy rating on the stock.
Several other analysts have also issued reports on ONT. Citigroup reiterated a buy rating and set a GBX 210 ($2.66) price target on shares of Oxford Nanopore Technologies in a research report on Friday, April 12th. JPMorgan Chase & Co. restated an overweight rating on shares of Oxford Nanopore Technologies in a research report on Thursday, May 23rd. Finally, Royal Bank of Canada reiterated an outperform rating and issued a GBX 260 ($3.29) target price on shares of Oxford Nanopore Technologies in a research report on Friday, June 28th. Five analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, Oxford Nanopore Technologies currently has a consensus rating of Buy and a consensus target price of GBX 276.75 ($3.50).
Check Out Our Latest Stock Analysis on ONT
Oxford Nanopore Technologies Price Performance
Insider Activity at Oxford Nanopore Technologies
In other Oxford Nanopore Technologies news, insider Gurdial (Gordon) Sanghera sold 1,203,967 shares of the company’s stock in a transaction dated Friday, June 28th. The stock was sold at an average price of GBX 92 ($1.16), for a total value of £1,107,649.64 ($1,401,024.08). In other Oxford Nanopore Technologies news, insider Gurdial (Gordon) Sanghera sold 1,203,967 shares of the firm’s stock in a transaction that occurred on Friday, June 28th. The shares were sold at an average price of GBX 92 ($1.16), for a total transaction of £1,107,649.64 ($1,401,024.08). Also, insider Kate Priestman acquired 23,564 shares of Oxford Nanopore Technologies stock in a transaction dated Tuesday, April 30th. The stock was purchased at an average cost of GBX 106 ($1.34) per share, for a total transaction of £24,977.84 ($31,593.52). Insiders purchased 23,971 shares of company stock worth $2,542,560 over the last three months. Company insiders own 29.98% of the company’s stock.
Oxford Nanopore Technologies Company Profile
Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific.
See Also
- Five stocks we like better than Oxford Nanopore Technologies
- Investing in large cap stocks: Diving into big caps
- AbbVie Stock: A Perfect Dip for Investors to Buy
- 3 REITs to Buy and Hold for the Long Term
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
- How to Invest in Biotech Stocks
- GitLab Stock Rebounds: The Inside Story of Its Comeback
Receive News & Ratings for Oxford Nanopore Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Nanopore Technologies and related companies with MarketBeat.com's FREE daily email newsletter.